Hematology/Oncology

Top Story

Trial to assess CAR T-cell therapy for HER2-positive metastatic breast cancer

Trial to assess CAR T-cell therapy for HER2-positive metastatic breast cancer
January 19, 2019
Meeting NewsVideo

VIDEO: Trials explore optimal treatments, resistance in chronic lymphocytic leukemia

January 18, 2019
SAN DIEGO — In this video, HemOnc Today Editorial Board member John C. Byrd, MD, discusses two late-breaking abstracts presented at the ASH Annual…

FDA approves Ontruzant, biosimilar to Herceptin, for breast and gastric cancers

January 18, 2019
The FDA approved trastuzumab-dttb, a biosimilar to trastuzumab, for three cancer indications. Trastuzumab-dttb (Ontruzant, Samsung Biopesis), a HER2/NEU receptor…
In the Journals Plus

Chemoradiotherapy extends survival in limited-stage small cell lung cancer

January 18, 2019
Patients with stage I to stage II small cell lung cancer achieved long-term survival with acceptable adverse effects following chemoradiotherapy and prophylactic cranial…
FDA News

Government shutdown threatens biosimilar approvals, patent litigation

January 18, 2019
As the ongoing partial government shutdown continues in the United States, the FDA has approximately 5 weeks until drug user fees completely dry up, jeopardizing the…
More Headlines »
CME CNE

Improving Colorectal Cancer Screening and Prevention: Advances in Polyp Detection and Resection

This activity is supported by an educational grant from Aries Pharmaceuticals, Inc.

Colorectal cancer (CRC) is the third most common type of cancer worldwide and the second deadliest form of cancer in…
More »
Video
Meeting News

VIDEO: CV effects of vitamin D, omega-3 supplements remain unclear

November 24, 2018
More »
Resource Centers
ASH Annual Meeting and Exposition

ASH Annual Meeting and Exposition

CME

Exploring New Immune Checkpoint Inhibitor Paradigms in Advanced Melanoma

This activity is supported by an educational grant from Bristol-Myers Squibb.

Early detection and appropriate management of melanoma is imperative for optimal clinical outcomes. For patients…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next